Dream big. Build together.

Our Civilization team comprises leaders in the life sciences sector, including c-suite stars, top academics and industry titans. All here to help you build the future.

A founder-centric approach

Civilization Ventures supports founders to reach their full potential, rather than replacing them. We call our approach “mentor capital”. We’re here to foster your growth as a founder to help you build tomorrow’s generational company.

Shahram Seyedin-Noor

Founder + Managing Partner
Shahram founded Civilization Ventures to help other founders succeed after spending more than a decade starting, running and investing in life sciences companies.

Shahram is fortunate to have a dozen exits under his belt as a life sciences founder and investor, including Rewrite (acq. by Intellia), Rocket (listed on Nasdaq), SingularBio (acq. by Invitae), Lemonaid (acq. by 23andme), Counsyl (acq. by Myriad), and Avantome (acq. by Illumina), among many others.

Shahram was the founding CEO of Inspirna (originally named Rgenix), a biotech startup with two first-in-class clinical-stage therapeutics for cancer. He was also founding CFO and VP of Corporate Development at NextBio, a genomics software pioneer acquired by Illumina.

Shahram is passionate about keeping people and our planet healthy and thriving. Born in Iran, he came to the US as a child after his family escaped and was raised in Portland, Oregon. He went on to graduate from Pomona College with a degree in economics (with plenty of science, math and language courses thrown in), and obtained a JD from Harvard. Shahram loves spending time with his family in nature.

Sonia Maryam Setayesh (PhD)

Investment Partner
Sonia is an investment partner at Civilization Ventures, where she leverages her passion for innovation and multidisciplinary background in basic and translational research to spearhead the firm's scientific due diligence and run its Fellowship program.

Sonia earned her Ph.D. from the University of Southern California as an endowed fellow where she specialized in developing single cell diagnostic tools for precision oncology by integrating multiplexed molecular profiles and machine learning. During her time at USC, she successfully managed multiple projects across seven clinical trials, collaborating closely with clinical teams and key opinion leaders. Her work led to the invention of a patented precision medicine liquid biopsy test for early cancer detection and publications in Nature Breast Cancer and Blood. Sonia also has hands-on expertise in the development of clinical stage cancer immunotherapies.

As part of Civilization, Sonia is excited to play a key role in shaping the future of the biotech ecosystem by nurturing groundbreaking ideas and supporting the growth of its cutting-edge portfolio companies. While completing her PhD, Sonia was a Vice President of Partnerships at Nucleate and Vice President of Biotech Connection Los Angeles where she helped other PhDs enter the world of entrepreneurship.

Samir Malhotra

Investment Partner
As an investment partner at Civilization Ventures, Samir combines his experience from academia, consulting, pharma, and building startups to support founders on their journey as they create novel solutions for human health.

Samir was the founding COO at Replace Therapeutics, a gene editing pioneer that he helped scale from the ground up until its acquisition by Tome Biosciences in 2023. Samir was also Head of Strategy & Operations at Rewrite Therapeutics, where he played a key role in the company’s growth and eventual exit to Intellia Therapeutics. Prior to that Samir spent time building the global product strategy function at Jazz Pharmaceuticals and the cell and gene therapy practice at IQVIA.

Growing up with a mom who was a high school biology teacher, Samir developed a keen passion for cutting edge science from an early age. At Stanford, his work focused on regenerative medicine, going on to graduate with a degree in Human Biology with Honors. Samir enjoys exploring San Francisco with his friends and family.

Kelcee Everrette (PhD)

Associate
Kelcee is a part-time associate at Civilization Ventures, where she assists with due diligence, deal sourcing, and other special projects. She is currently a PhD candidate in the Biological and Biomedical Sciences Program at Harvard University. Her graduate work focuses on the therapeutic application of precision genome editors for rare diseases like sickle cell disease.

Before starting her doctoral studies, Kelcee graduated cum laude in Biomedical Engineering with a secondary in African American Studies from Harvard University. Kelcee hails from Ft. Worth, TX. She enjoys traveling, ceramics, and learning new languages in her free time.

Matt Wheeler, CPA

CFO
Matt is the CFO of Civilization Ventures where he leads the finance and accounting functions. Prior to joining Civilization Ventures, Matt had an extensive career in client service focused primarily on alternative investments.

Matt began working in alternatives after successfully completing the level 2 CFA exam where he audited hedge funds with a global public accounting firm. After that, he joined a premier fund administrator in their San Francisco headquarters where he focused primarily on serving venture capital clients. Matt is the founder of fund administrator Vector AIS where he helped build an industry-leading team.

Matt has a business degree from Western University and holds a CPA designation. In his spare time, Matt likes to snowboard, mountain bike, travel, cook, read books and seek adventures.
SHAHRAM SEYEDIN-NOOR
Founder + Managing Partner
SONIA SETAYESH, PhD
Investment Partner
Samir Malhotra
Investment Partner
KELCEE EVERRETTE, PhD
Associate
MATT WHEELER
CFO

30+ Fellows Across 3 Continents

We launched our Civilization Fellowship Program to help train tomorrow’s life sciences founders and investors. Our Fellowship program has now graduated more than 30 of the world’s brightest PhDs and MDs (and a few MBAs) with their virtual diplomas in the art and science of biotech investing!

Our Fellowship is carefully structured to walk through key facets of the venture lifecycle - from sourcing opportunities, to conducting due diligence and writing investment memoranda. One of the highlights of the program is our fireside chat series with today’s rising star founders as well as industry veterans.

Sign up here to get an application for our upcoming Fellowship class.
Apply now

Fellows

pagination
pagination
pagination
pagination
pagination
pagination
32 fellows who hold PhDs
9 fellows who hold MDs
5 fellows who hold MBAs

Advisors

Global Network of Advisors

Civilization Ventures leverages an extensive network of world-class life science leaders, academics and clinicians - including public company executives and dozens of PhDs and MDs - to gain access to and understand the leading innovations in our space.

Our network is truly global, with key advisors located in Silicon Valley, Cambridge and NY in the US, as well as Europe and Asia. Our advisors are leading figures and researchers across key innovation sectors, including genomics and diagnostics, artificial intelligence, gene and cell therapies, and regenerative medicine. Our international reach and deep domain expertise has enabled us to invest in exponential health technologies and synthetic biology companies worldwide, with founders who have earned advanced degrees from leading academic institutions such as Harvard, Stanford, Berkeley, MIT, Columbia, Oxford, Cambridge, Caltech, among other top institutions.

Our mission is to back disruptive innovation that has the potential to advance human longevity and our shared civilization.